Google
Trusted Resources: News & Events
Latest announcements and gatherings
MARAC Advisory Statement: Monoclonal Antibodies Against SARS-CoV-2
August 26, 2021 – The Sickle Cell Disease Association of America Medical and Research Advisory Committee has released a statement with updated COVID-19 guidance.
MARAC recommends that people with sickle cell disease should have access to monoclonal antibody (mAbs) treatment according to established guidelines, to prevent mild COVID from progressing to severe disease.
Read the full recommendations for providers, policy makers and patients.
+myBinderRelated Content
-
Managing Sickle Cell Disease as an AdultPeople with sickle cell disease (SCD) ar...
-
Sickle Cell Society IrelandSickle Cell Society Ireland (SCSI) is th...
-
Rare Disease Day Symposium at the Quinnipiac Frank H. Netter MD School of MedicineSince 2015, the Frank H. Netter MD Schoo...
-
Sickle Cell Disease Managing Painhttps://www.onescdvoice.com/wp-content/u...
-
Sickle Cell Disease Association of North TexasSickle Cell Disease Association of North...
-
Coronavirus Questions: Getting Answers From the Expertshttps://www.youtube.com/watch?v=iFavuPKV...
-
Facebook Live: Stem Cells and Sickle Cell Diseasehttps://www.youtube.com/watch?v=IPzNx8i_...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
SomeBodyToTalkTo connects people affected by rare diseases with trusted resources, supportive communities, and opportunities to share their experiences.